FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)

View source ↗

Summary

The FDA approves a supplemental application for AIMOVIG (erenumab-aooe) from Amgen, resulting in a labeling change.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• AIMOVIG (ERENUMAB-AOOE)

Snippet

SUPPL AP for AIMOVIG (ERENUMAB-AOOE)